(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENDOCEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ENDOCEUTICS

ST13

US500000077880488

Class

5, 35, 40, 41, 42

Filing

77880488

Registration

6181907

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

123

Latest update

10/28/2025

Trademark type

Word

Nice classes

5, 35, 40, 41, 42

Filing date

11/25/2009

Registration date

10/27/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/27/2020

Last transaction

10/28/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Quebec City, QUÉBEC, CA

Examiner

POWELL, LINDA

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Endoceutics Inc.

Representatives

Michael J. Leonard Fox Rothschild LLP

Technical classification

Nice Classes

Class 5Class 35Class 40Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the prevention and treatment of menopausesexual dysfunctionvaginal atrophydecreased libidogynaecological disorders; Pharmaceutical preparations and substances for the prevention and treatment of menopausal problemsneoplasiabreast neoplasmbreast cancermastopathymastodynia; Pharmaceutical preparations and substances for the treatment of the endocrine system; Pharmaceutical preparations and substances for the prevention and treatment of oily skinacnemale baldness; Pharmaceutical preparations and substances for the prevention and treatment of obesityhigh cholesteroldiabetesloss of muscle and mass strengthbone loss

Class 35

Wholesale distributorship of pharmaceuticals for others

Class 40

Custom manufacture of pharmaceutical products to the order and specification of others

Class 41

Pharmaceutical educational services and patient educational servicesproviding classesworkshops and seminars in the field of treatment and prevention of endocrine-related disorders and diseases

Class 42

Research and development in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals

Publications

History of USPTO decisions and trademark events.

123 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/27/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/27/2020

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

09/17/2020

CHPB

POST PUBLICATION AMENDMENT - ENTERED

05/06/2020

APET

ASSIGNED TO PETITION STAFF

05/04/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

04/09/2020

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

03/17/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/10/2020

PUBO

PUBLISHED FOR OPPOSITION

03/10/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/19/2020

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

02/03/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/03/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

02/03/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/03/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

02/03/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/03/2020

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

02/03/2020

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

01/31/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/24/2020

ATRV

ATTORNEY REVIEW COMPLETED

01/24/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/24/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/24/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/05/2019

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/05/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/05/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/15/2019

GNSL

LETTER OF SUSPENSION E-MAILED

05/15/2019

CNSL

SUSPENSION LETTER WRITTEN

05/15/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/02/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/02/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/29/2019

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/29/2018

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/29/2018

CNSI

SUSPENSION INQUIRY WRITTEN

10/29/2018

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

10/25/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/22/2018

GNSL

LETTER OF SUSPENSION E-MAILED

03/22/2018

CNSL

SUSPENSION LETTER WRITTEN

03/22/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/12/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2018

ALIE

ASSIGNED TO LIE

03/08/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/02/2018

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

09/09/2017

GNSI

INQUIRY TO SUSPENSION E-MAILED

09/09/2017

CNSI

SUSPENSION INQUIRY WRITTEN

09/09/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

09/07/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/02/2017

GNSL

LETTER OF SUSPENSION E-MAILED

03/02/2017

CNSL

SUSPENSION LETTER WRITTEN

03/02/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/16/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/16/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/13/2017

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

08/13/2016

GNSI

INQUIRY TO SUSPENSION E-MAILED

08/13/2016

CNSI

SUSPENSION INQUIRY WRITTEN

08/13/2016

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

08/09/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/04/2016

GNSL

LETTER OF SUSPENSION E-MAILED

02/04/2016

CNSL

SUSPENSION LETTER WRITTEN

02/04/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/27/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/27/2016

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/22/2016

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

07/22/2015

GNSI

INQUIRY TO SUSPENSION E-MAILED

07/22/2015

CNSI

SUSPENSION INQUIRY WRITTEN

07/22/2015

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

07/15/2015

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/15/2015

GNSL

LETTER OF SUSPENSION E-MAILED

01/15/2015

CNSL

SUSPENSION LETTER WRITTEN

01/15/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/30/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/30/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/24/2014

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/24/2014

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

06/26/2014

GNSI

INQUIRY TO SUSPENSION E-MAILED

06/26/2014

CNSI

SUSPENSION INQUIRY WRITTEN

06/26/2014

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

06/24/2014

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/18/2013

GNSL

LETTER OF SUSPENSION E-MAILED

12/18/2013

CNSL

SUSPENSION LETTER WRITTEN

12/18/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/11/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/11/2013

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/11/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/02/2013

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/02/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/17/2013

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

06/03/2013

GNSI

INQUIRY TO SUSPENSION E-MAILED

06/03/2013

CNSI

SUSPENSION INQUIRY WRITTEN

06/03/2013

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/08/2012

GNSL

LETTER OF SUSPENSION E-MAILED

11/08/2012

CNSL

SUSPENSION LETTER WRITTEN

11/08/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/02/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/02/2012

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/25/2012

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

04/28/2012

GNSI

INQUIRY TO SUSPENSION E-MAILED

04/28/2012

CNSI

SUSPENSION INQUIRY WRITTEN

04/28/2012

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

04/23/2012

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/19/2011

GNSL

LETTER OF SUSPENSION E-MAILED

10/19/2011

CNSL

SUSPENSION LETTER WRITTEN

10/19/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/29/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/29/2011

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/08/2011

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

03/11/2011

GNSI

INQUIRY TO SUSPENSION E-MAILED

03/11/2011

CNSI

SUSPENSION INQUIRY WRITTEN

03/11/2011

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

03/09/2011

ALIE

ASSIGNED TO LIE

03/09/2011

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/09/2010

GNSL

LETTER OF SUSPENSION E-MAILED

09/09/2010

CNSL

SUSPENSION LETTER WRITTEN

09/09/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/08/2010

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/02/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/08/2010

GNRT

NON-FINAL ACTION E-MAILED

03/08/2010

CNRT

NON-FINAL ACTION WRITTEN

03/08/2010

DOCK

ASSIGNED TO EXAMINER

03/02/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/01/2009

NWAP

NEW APPLICATION ENTERED

11/28/2009

Continuous trademark protection

Get notified about every new filing that threatens ENDOCEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.